REPORT ID 13722

Global ADHD Drugs Market Research Report 2017

Publish Date
22-Nov-17
Pages
109
Format
Electronic (PDF)

In this report, the global ADHD Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ADHD Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global ADHD Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Eli Lilly
    Janssen Pharmaceuticals, Inc.
    Shire
    Perdue Pharma
    Glaxosmith Kline
    Novartis
    Celltech Group
    Johnson & Johnson
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Stimulants (Amphetamines, Methylphenidate)
    Non-Stimulants
    Antidepressants
    Blood Pressure Medicines
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Adults
    Children

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global ADHD Drugs Market Research Report 2017
1 ADHD Drugs Market Overview
    1.1 Product Overview and Scope of ADHD Drugs
    1.2 ADHD Drugs Segment by Type (Product Category)
        1.2.1 Global ADHD Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global ADHD Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Stimulants (Amphetamines, Methylphenidate)
        1.2.4 Non-Stimulants
        1.2.5 Antidepressants
        1.2.6 Blood Pressure Medicines
    1.3 Global ADHD Drugs Segment by Application
        1.3.1 ADHD Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Adults
        1.3.3 Children
    1.4 Global ADHD Drugs Market by Region (2012-2022)
        1.4.1 Global ADHD Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of ADHD Drugs (2012-2022)
        1.5.1 Global ADHD Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global ADHD Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global ADHD Drugs Market Competition by Manufacturers
    2.1 Global ADHD Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global ADHD Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global ADHD Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global ADHD Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global ADHD Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers ADHD Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 ADHD Drugs Market Competitive Situation and Trends
        2.5.1 ADHD Drugs Market Concentration Rate
        2.5.2 ADHD Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global ADHD Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global ADHD Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global ADHD Drugs Production and Market Share by Region (2012-2017)
    3.3 Global ADHD Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global ADHD Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global ADHD Drugs Consumption by Region (2012-2017)
    4.2 North America ADHD Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe ADHD Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China ADHD Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan ADHD Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia ADHD Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India ADHD Drugs Production, Consumption, Export, Import (2012-2017)

5 Global ADHD Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global ADHD Drugs Production and Market Share by Type (2012-2017)
    5.2 Global ADHD Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global ADHD Drugs Price by Type (2012-2017)
    5.4 Global ADHD Drugs Production Growth by Type (2012-2017)

6 Global ADHD Drugs Market Analysis by Application
    6.1 Global ADHD Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global ADHD Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global ADHD Drugs Manufacturers Profiles/Analysis
    7.1 Eli Lilly
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 ADHD Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Eli Lilly ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Janssen Pharmaceuticals, Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 ADHD Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Shire
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 ADHD Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Shire ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Perdue Pharma
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 ADHD Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Perdue Pharma ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Glaxosmith Kline
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 ADHD Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Glaxosmith Kline ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Novartis
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 ADHD Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Novartis ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Celltech Group
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 ADHD Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Celltech Group ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Johnson & Johnson
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 ADHD Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Johnson & Johnson ADHD Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview

8 ADHD Drugs Manufacturing Cost Analysis
    8.1 ADHD Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of ADHD Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 ADHD Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global ADHD Drugs Market Forecast (2017-2022)
    12.1 Global ADHD Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global ADHD Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global ADHD Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global ADHD Drugs Price and Trend Forecast (2017-2022)
    12.2 Global ADHD Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America ADHD Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe ADHD Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China ADHD Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan ADHD Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia ADHD Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India ADHD Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global ADHD Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global ADHD Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer